| Patient | Rachel Carson |
|---|---|
| Date of birth | 1907-05-27 |
| Identifiers | MRN HR-ML041-SYN-TD; SSN (made up) 000-41-5068 |
| Document date | 1960-03-18 |
| Author | Margaret Vance-Okonkwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Results of the breast imaging and biopsy. [S]
Ms. Carson returns nine days after presenting with a firm lump in the upper outer left breast. The diagnostic mammogram and ultrasound a week ago showed a 2.4 cm irregular spiculated mass at 2 o'clock, BI-RADS 5, with normal axillary nodes. The ultrasound-guided core biopsy five days ago shows invasive ductal carcinoma, grade 2, ER 95 percent, PR 80 percent, HER2 1+ (negative), Ki-67 22 percent. Before the result was given she was asked what she wanted to know and how; she said she wanted all of it, plainly, and the report in her hand. She was told directly that the biopsy shows breast cancer, that it appears to be early and confined to the breast, and that the aim of treatment is cure. In her own words back she described an early cancer fed by estrogen, to be removed by surgery, with lymph node testing at the operation. She met Dr. Solís-Abernathy this morning and, after hearing the choice between breast-conserving surgery with radiation and mastectomy, chose breast-conserving surgery. She has no bone pain, cough, headache, or weight loss. Her ulcer pain has gone and she is taking omeprazole. She asked that her diagnosis be shared only with a close friend and her editor, and that she be the one to tell them. [S]
| Element | Detail |
|---|---|
| Interval change | Imaging BI-RADS 5; core biopsy invasive ductal carcinoma, ER and PR positive, HER2 negative |
| Disclosure | Told the diagnosis in person in plain words; report copy given; teach-back correct |
| Her decision | Breast-conserving surgery with sentinel node biopsy, after both options were explained |
| Coordination | Breast surgical oncology seen this morning |
| Privacy | Diagnosis to be shared only with the two people she names, by her |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No weight loss, fever, or night sweats |
| Breast | Positive | Left breast lump with a small bruise from the biopsy; no nipple discharge or skin change |
| Musculoskeletal | Negative | No bone or back pain; knee stiffness unchanged |
| Gastrointestinal | Negative | No epigastric pain, black stools, or vomiting |
| Respiratory | Negative | No cough or breathlessness |
| Psychiatric | Positive | Worried and sleeping less since the biopsy; PHQ-9 6, GAD-7 8 |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth once daily before breakfast, to complete eight weeks of ulcer healing | One capsule once daily before breakfast | Oral route | 1960-01-19 to 1960-04-03 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for knee pain, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 1959-06-02 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1960-03-18 | Body height | 163 | cm | S |
| 1960-03-18 | Body weight | 59 | kg | S |
| 1960-03-18 | Body mass index (BMI) [Ratio] | 22.2 | kg/m2 | S |
| 1960-03-18 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1960-03-18 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1960-03-18 | Heart rate | 84 | /min | S |
| 1960-03-18 | Respiratory rate | 16 | /min | S |
| 1960-03-18 | Body temperature | 36.6 | Cel | S |
| 1960-03-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1960-03-18 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1960-03-18 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S |
Vital signs recorded on 1960-03-18; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Composed and attentive; takes notes |
| Breasts | Left breast: 2.5 cm hard, irregular mass at 2 o'clock, mobile on the chest wall, with a small bruise at the biopsy site; no skin dimpling or nipple change. Right breast normal |
| Lymph nodes | No axillary, supraclavicular, or infraclavicular nodes |
| Abdomen | Soft; no epigastric tenderness; liver not enlarged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Invasive ductal carcinoma of the left breast, upper outer quadrant at 2 o'clock, 2.4 cm on imaging; core biopsy grade 2, estrogen and progesterone receptor positive, HER2 negative, Ki-67 22 percent; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern counterpart of the documented 1894 breast cancer, which was not disclosed to her | active | confirmed | C50.412 | S — Synthetic tumor details, stage, and treatment; the breast lumps, the 1960 operation, and the nondisclosure are documented (D), but no tumor details from her lifetime are used. |
| Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 80 percent) | active | confirmed | Z17.0 | S — Synthetic receptor result; no receptor status from her lifetime is known. |
| New firm lump in the upper outer quadrant of the left breast, found two weeks ago; clinically suspicious; diagnostic imaging and biopsy booked | resolved | confirmed | N63.21 | S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the lumps in the left breast in early 1960 are documented (D). |
| Duodenal ulcer found at endoscopy seven weeks ago, with Helicobacter pylori on biopsy; treated with 14 days of bismuth quadruple therapy and completing eight weeks of omeprazole; test of cure planned | active | confirmed | K26.9 | S — Synthetic modern ulcer; it echoes the ulcer among her documented illnesses, which the sources do not date. |
| Primary osteoarthritis of both knees, mild, with stiffness after long walks on the shore | active | confirmed | M17.0 | S — Synthetic condition; it is not linked to the documented word arthritis, which she may have used to keep her cancer private. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Diagnostic mammography and ultrasound of the breast and axilla | At presentation with a palpable mass | Up to date | Done a week ago: 2.4 cm spiculated mass, BI-RADS 5; normal axillary nodes |
| Laboratory | Core biopsy with ER, PR, HER2, and Ki-67 | At diagnosis | Up to date | Invasive ductal carcinoma, grade 2; ER 95 percent, PR 80 percent, HER2 1+ (negative), Ki-67 22 percent |
| Self-management | Disclosure of the diagnosis and shared decision-making | At diagnosis and at every result | Completed today | Asked what she wanted to know; told in person in plain words; report copy given; teach-back correct; surgical choice made by her |
| Imaging | Breast MRI for extent of disease | Optional; considered for dense breasts or uncertain extent | Not indicated | Single lesion in breasts of scattered density; decided with Dr. Solís-Abernathy |
| Imaging | CT, bone scan, or PET for distant spread | Only with symptoms or clinical stage III | Not indicated | Clinical stage T2 N0 with no symptoms of spread |
| Laboratory | Tumor markers (CEA, CA 15-3, CA 27.29) | Not recommended for early breast cancer | Not indicated | Not ordered |
| Laboratory | Germline genetic testing | At diagnosis, for breast cancer at 65 or younger | Completed today | Genetic counseling and a multigene panel today; result expected before surgery |
| Survey | Distress, depression, and anxiety screen (PHQ-9 and GAD-7) | At diagnosis and at periodic intervals | Completed today | PHQ-9 6 and GAD-7 8, mild; offered the cancer center's counseling service, which she will consider |
| Examination | Baseline arm measurements for later lymphedema checks | Before axillary surgery | Due | To be measured at the pre-operative visit |
| Referral | Breast surgical oncology | At diagnosis | Completed today | Seen this morning; recommendations in the consultation note |
| Referral | Medical and radiation oncology | After surgery, with the surgical pathology | Due | To review the pathology and recurrence score after surgery |
| Medication safety | Avoid nonsteroidal anti-inflammatory drugs after surgery | Perioperative, after a recent duodenal ulcer | Completed today | Surgical team informed; acetaminophen for pain |
| Laboratory | Helicobacter pylori test of cure | At least four weeks after antibiotics and two weeks off a proton pump inhibitor | Due | Urea breath test planned after surgery |
Goal progress:
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Code of Medical Ethics Opinion 2.1.3: Withholding Information from Patients (2016); Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. J Clin Oncol 2017;35(31):3618-3632 (2017); Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol 2024 (2024); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026)
Follow-up: Genetic result before surgery. Lumpectomy within three weeks. Primary care review about two weeks after surgery, with the pathology. Next scheduled visit 1960-04-20: review two weeks after lumpectomy and sentinel node biopsy: full disclosure of the pathology and the adjuvant treatment decision. [S]